Modulation of Immune Functions by Foods

被引:63
作者
Kaminogawa, Shuichi [1 ]
Nanno, Masanobu [1 ]
机构
[1] Nihon Univ, Dept Food Sci & Technol, Coll Bioresource Sci, Fujisawa, Kanagawa 2528510, Japan
关键词
amino acid; fatty acid; lactic acid bacteria; mineral; oligosaccharide; polyphenol; vitamin;
D O I
10.1093/ecam/neh042
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Evidence is rapidly accumulating as to the beneficial effects of foods. However, it is not always clear whether the information is based on data evaluated impartially in a scientific fashion. Human research into whether foods modulate immune functions in either intervention studies or randomized controlled trials can be classified into three categories according to the physical state of subjects enrolled for investigation: (i) studies examining the effect of foods in healthy individuals; (ii) studies analyzing the effect of foods on patients with hypersensitivity; and (iii) studies checking the effect of foods on immunocompromized subjects, including patients who had undergone surgical resection of cancer and newborns. The systematization of reported studies has made it reasonable to conclude that foods are able to modulate immune functions manifesting as either innate immunity (phagocytic activity, NK cell activity) or acquired immunity (T cell response, antibody production). Moreover, improvement of immune functions by foods can normalize the physical state of allergic patients or cancer patients, and may reduce the risk of diseases in healthy individuals. Therefore, it is valuable to assess the immune-modulating abilities of foods by measuring at least one parameter of either innate or acquired immunity.
引用
收藏
页码:241 / 250
页数:10
相关论文
共 159 条
[61]   Decrease in ovalbumin specific IgE of mice serum after oral uptake of lactic acid bacteria [J].
Ishida, Y ;
Bandou, I ;
Kanzato, H ;
Yamamoto, N .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2003, 67 (05) :951-957
[62]  
Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x
[63]  
Ito H, 1998, ARZNEIMITTELFORSCH, V48, P1143
[64]  
JACKSON PG, 1981, LANCET, V1, P1285
[65]   Epidermal cytokines IL-1β, TNF-α, and IL-12 in patients with atopic dermatitis:: Response to application of house dust mite antigens [J].
Junghans, V ;
Gutgesell, C ;
Jung, T ;
Neumann, C .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 111 (06) :1184-1188
[66]   Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis [J].
Kaburagi, Y ;
Shimada, Y ;
Nagaoka, T ;
Hasegawa, M ;
Takehara, K ;
Sato, S .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2001, 293 (07) :350-355
[67]   CORRELATION OF EOSINOPHILS, EOSINOPHIL CATIONIC PROTEIN AND SOLUBLE INTERLEUKIN-2 RECEPTOR WITH THE CLINICAL ACTIVITY OF ATOPIC-DERMATITIS [J].
KAGI, MK ;
JOLLERJEMELKA, H ;
WUTHRICH, B .
DERMATOLOGY, 1992, 185 (02) :88-92
[68]   ENHANCEMENT OF THE CIRCULATING ANTIBODY SECRETING CELL RESPONSE IN HUMAN DIARRHEA BY A HUMAN LACTOBACILLUS STRAIN [J].
KAILA, M ;
ISOLAURI, E ;
SOPPI, E ;
VIRTANEN, E ;
LAINE, S ;
ARVILOMMI, H .
PEDIATRIC RESEARCH, 1992, 32 (02) :141-144
[69]   Probiotics and prevention of atopic disease:: 4-year follow-up of a randomised placebo-controlled trial [J].
Kalliomäki, M ;
Salminen, S ;
Poussa, T ;
Arvilommi, H ;
Isolauri, E .
LANCET, 2003, 361 (9372) :1869-1871
[70]   Probiotics in primary prevention of atopic disease:: a randomised placebo-controlled trial [J].
Kalliomäki, M ;
Salminen, S ;
Arvilommi, H ;
Kero, P ;
Koskinen, P ;
Isolauri, E .
LANCET, 2001, 357 (9262) :1076-1079